Back to search

Netherlands· NL-4cf63fee5cb6

Myoview 230 microgram kit voor radiofarmaceutisch preparaat

A 99mtc-technetium-tetrofosmin product containing tetrofosmine, registered in Netherlands by GE Healthcare B.V.. The same ATC class is registered in 8 of our 19 countries.

ATC V09GA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMyoview 230 microgram kit voor radiof…ATCV09GA02REGISTER NO.NL-4cf63fee5cb6PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

99mtc-technetium-tetrofosmin is registered in 8 of 19 countries.

Countries holding a registration under ATC V09GA02 (99mtc-technetium-tetrofosmin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose

99mtc-technetium-tetrofosmin · ATC V09GA02

8 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TETROFOSMINE
Manufacturer
GE Healthcare B.V.
Country
Netherlands (NL)
ATC code
V09GA02
ATC class
99mTc-Technetium-Tetrofosmin
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    16323

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for 99mtc-technetium-tetrofosmin.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

99mtc-technetium-tetrofosmin · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • Amyl nitriteV03AB22moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

99mtc-technetium-tetrofosmin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All 99mtc-technetium-tetrofosmin products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Myoview, Tetrofosmin Rotop
  • Belgium · Myoview, Tetrofosmin Rotop
  • Bulgaria · Майовю
  • Cyprus · Myoview
  • Czechia · Myoview
  • Germany · Myoview, Tetrofosmin Rotop
  • Denmark · Myoview
  • Spain · Myoview, Tetrofosmina Rotop
  • Finland · Myoview, Tetrofosmin Rotop
  • France · Myoview
  • United Kingdom (Northern Ireland) · Myoview, Tetrofosmin Rotop
  • Greece · Myoview, Tetrofosmin Rotop
  • Hungary · Myoview
  • Ireland · Myoview
  • Italy · Myoview
  • Luxembourg · Myoview
  • Malta · Myoview
  • Norway · Myoview
  • Portugal · Myoview, Tetrofosmina Rotop
  • Sweden · Myoview, Tetrofosmin Rotop
  • Slovakia · Myoview

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ea20bc8e-4ac4-4cca-8965-d20686fecda2
GET /v1/drugs/ea20bc8e-4ac4-4cca-8965-d20686fecda2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kit voor radiofarmaceutisch preparaat",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h16323_smpc.pdf",
  "strength": null,
  "atc_label": "Technetium (99m Tc) Tetrofosmin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg16323",
  "excipients": [
    "DISODIUM SULPHOSALICYLATE (RI)",
    "NATRIUMGLUCONAAT (E 576)",
    "NATRIUMWATERSTOFCARBONAAT (E 500 (II))",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "TINDICHLORIDE 2-WATER (E 512)"
  ],
  "substances": [
    "TETROFOSMINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h16323.pdf",
  "authorised_at": "1994/01/25",
  "procedure_number": "DK/H/2989/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "16323",
  "additional_monitoring": "N"
}

See everything about 99mtc-technetium-tetrofosmin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.